8 October 2018: The United States-Mexico-Canada Agreement (“USMCA”), a remodelling of the North American Free Trade Agreement (“NAFTA”), has serious implications for data privacy and usage for consumers in those countries and around the world according to Michael Geist in a Washington Post article.
Trump Trade Wars
Updates on US trade initiatives under President Donald Trump
4 October 2018: Investor-State Dispute Settlement (ISDS) provisions in trade deals enable foreign investors to bypass national courts and sue governments in international tribunals if they can argue that a change in law or policy has harmed their investment.
The revamped NAFTA agreement between the US, Mexico and Canada, now called the United States-Mexico-Canada Agreement, will phase out ISDS between the US and Canada altogether after three years. The deal also limits the scope for ISDS cases between the US and Mexico to cases of direct government takeover of assets.
24 September 2018: Trade wars are intensifying today between the US and China in the lead up to early November mid-term Congressional elections. As the US tries to gain domestic political advantage, the latest round of retaliatory measures between the world’s largest economies will mean repercussions for workers around the world, who are already most disadvantaged by unfair trading systems.
July 25, 2018: The US Trump administration is escalating its America First strategy of using its power as the world’s strongest economy to get more benefits for US corporations from individual trading partners, in the hope of domestic political advantage in the mid-term Congressional elections due in November 2018. But there are long-term consequences for the global economy and the global trading system.
June 13, 2018: US President Donald Trump wrecked the furniture in the ‘global free trade’ shop at last week’s G7 meeting in Canada, making retaliatory tariffs by Canada, Europe and Mexico against US exports inevitable.
Media Release, May 14, 2018: “US President Donald Trump’s policy to end “freeloading” and force trading partners to increase prices they pay for US pharmaceutical exports is a direct threat to Australia’s policy of ensuring affordable medicines through our Pharmaceutical Benefits Scheme,” AFTINET Convener Dr Patricia Ranald said today.
“This policy results from the US pharmaceutical companies absurd and unproven argument that if other governments abandon their affordable medicine policies and agree to higher prices, the companies would then lower their prices in the US. Both Canada and New Zealand have strongly rejected this push. There has so far been no reported response from the Turnbull government. We call on the government to reject this policy,” said Dr Ranald.
March 26, 2018: US trade policy has become more dangerously unilateral and contradictory.
US President Trump threatened on March 23 to impose tariffs on US$60 billion of Chinese exports to the US after a “consultation” period. This is also linked to US strategic and military competition with China. China has threatened to retaliate with its own tariffs on US goods, resulting in a trade war and economic instability. Global stock markets plunged in response to the news.
March 19, 2018: Jim Stanford from the Australia Institute writes in The Guardian that Trump’s unilateral and xenophobic approach to trade policy is dangerous and could lead to trade conflict. He argues we need an alternative to both Trump’s unilateralism and to corporate-dominated trade deals like the TPP.